RIL
CGEM icon

Rothschild Investment LLC’s Cullinan Oncology CGEM Stock Holding History

Rothschild Investment LLC’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.69K Buy
189
+156
+473% +$2K ﹤0.01% 2403
2025
Q4 		$342 Buy
33
+3
+10% +$27 ﹤0.01% 3018
2025
Q3 		$178 Hold
30
– – ﹤0.01% 3016
2025
Q2 		$226 Sell
30
-215
-88% -$1.73K ﹤0.01% 2919
2025
Q1 		$1.85K Buy
+245
New +$2.35K ﹤0.01% 1943
2024
Q4 		– Sell
-60
Closed -$1K – 2972
2024
Q3 		$1K Buy
60
+35
+140% +$621 ﹤0.01% 2167
2024
Q2 		$436 Buy
+25
New +$532 ﹤0.01% 2105

Other funds holding CGEM

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Rothschild Investment LLC's CGEM Position: Q1 2026 in Review

Rothschild Investment LLC increased its Cullinan Oncology (CGEM) stake by 473% in Q1 2026, buying an estimated $2K and bringing the position to 189 shares worth $2.69K. The position accounts for ﹤0.01% of the portfolio, ranked #2403.

Rothschild Investment LLC first reported a position in CGEM in Q2 2024 and has held it in 7 quarters since. 174 funds tracked by Wall St. Rank hold CGEM as of Q1 2026.

  • Rothschild Investment LLC held 189 shares of Cullinan Oncology worth $2.69K as of Q1 2026.
  • Rothschild Investment LLC bought 156 Cullinan Oncology shares in Q1 2026, an estimated $2K.
  • Cullinan Oncology made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q1 2026, its #2403 holding.
  • Rothschild Investment LLC first reported a position in Cullinan Oncology in Q2 2024 and has held it in 7 quarters since.
  • 174 funds tracked by Wall St. Rank held Cullinan Oncology as of Q1 2026.

Based on Rothschild Investment LLC's 13F filing for Q1 2026, filed 7 May 2026.